[go: up one dir, main page]

PE20212213A1 - VBI STRAINS AND USES OF THE SAME - Google Patents

VBI STRAINS AND USES OF THE SAME

Info

Publication number
PE20212213A1
PE20212213A1 PE2021001672A PE2021001672A PE20212213A1 PE 20212213 A1 PE20212213 A1 PE 20212213A1 PE 2021001672 A PE2021001672 A PE 2021001672A PE 2021001672 A PE2021001672 A PE 2021001672A PE 20212213 A1 PE20212213 A1 PE 20212213A1
Authority
PE
Peru
Prior art keywords
ibv
attenuated
vbi
strains
same
Prior art date
Application number
PE2021001672A
Other languages
Spanish (es)
Inventor
Jorge Luis Chacon
Anna Kollar
Zoltan Nagy
Zoltan Penzes
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of PE20212213A1 publication Critical patent/PE20212213A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion define un virus de la bronquitis infecciosa (VBI) atenuado que comprende un gen S1 que tiene una secuencia de nucleotidos de SEQ ID NO: 1, un VBI inactivado obtenible inactivando un VBI atenuado, una vacuna que comprende el VBI atenuado, un cultivo in vitro de celulas infectadas por el VBI atenuado, y un metodo para preparar dicha vacunaThe present invention defines an attenuated infectious bronchitis virus (IBV) comprising an S1 gene having a nucleotide sequence of SEQ ID NO: 1, an inactivated IBV obtainable by inactivating an attenuated IBV, a vaccine comprising attenuated IBV, an in vitro culture of cells infected by attenuated IBV, and a method for preparing said vaccine

PE2021001672A 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME PE20212213A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102015025152A BR102015025152A8 (en) 2015-09-30 2015-09-30 infectious bronchitis virus, inactivated infectious bronchitis virus, nucleic acid, vector, polypeptide, vaccine, use of a strain of vbi, method for protecting poultry against infectious bronchitis virus, cell, method for preparing a vaccine, and method for detect vbi in a sample

Publications (1)

Publication Number Publication Date
PE20212213A1 true PE20212213A1 (en) 2021-11-19

Family

ID=58543698

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2016001848A PE20170763A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME
PE2021001672A PE20212213A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2016001848A PE20170763A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME

Country Status (3)

Country Link
AR (1) AR106207A1 (en)
BR (1) BR102015025152A8 (en)
PE (2) PE20170763A1 (en)

Also Published As

Publication number Publication date
BR102015025152A2 (en) 2017-04-04
BR102015025152A8 (en) 2021-08-10
AR106207A1 (en) 2017-12-20
PE20170763A1 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
PH12018501602A1 (en) Subunit immersion vaccines for fish
CY1124618T1 (en) RECOMBINANT HVT VECTORS EXPRESSING Avian PATHOGEN ANTIGENS AND USES THEREOF
MX2020013153A (en) Methods and compositions for inducing protective immunity against human immunodeficiency virus infection.
CO2018005265A2 (en) Nucleic acid vaccines for varicella-zoster virus
BR112018008090A2 (en) herpes simplex virus vaccine.
CY1111378T1 (en) Cell-derived viral vaccines with low levels of residual cellular DNA
CO2018006706A2 (en) Mutated viruses, method of preparation and use thereof
MX2022006603A (en) Broad spectrum influenza virus vaccine.
MX2018008413A (en) Modified oncolytic viurs.
PE20150334A1 (en) MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES TO IMMUNIZE AVIAN SPECIES
EP4043031A3 (en) Zika viral antigen constructs
MX2019004593A (en) RECOMBINANT VECTORS THAT EXPRESS ANTIGENS OF AVIAN INFLUENZA VIRUSES AND USES OF THE SAME.
CL2012000447A1 (en) Composition or vaccine comprising a recombinant avian paramyxovirus 8 (apmv-8) viral vector; method of producing said vector; and use to prepare medicament useful for inducing an immune response.
UA108902C2 (en) NORTH AMERICAN REPRODUCTIVE AND RESPIRATORY PIG SYNDROME (PRRS) VIRUS
BR112017011582A2 (en) immortalized chicken embryo fibroblasts, cell culture, methods for preparing an imported cef, for replicating an avian viral vector and for preparing a vaccine, and, vaccine.
PH12016500500A1 (en) A viral vaccine and methods of manufacture thereof
BR112018012642A2 (en) feline calicivirus vaccine
CU24580B1 (en) ATTENUATED VECTORS OF INFLUENZA FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
CO7461133A2 (en) Parvovirus 5a pig, methods of use and vaccine
PH12014500369A1 (en) Influenza h5 vaccines
AR113124A1 (en) PARAMYXOVIRIDAE EXPRESSION SYSTEM
CL2021003211A1 (en) A modified live strain of porcine reproductive and respiratory syndrome virus (prrs), a vaccine comprising it and its use to treat prrs type ii. (divisional application no. 2123-2018)
CO2017001614A2 (en) Recombinant vector vaccine for avian adenovirus serotype 9
CO7461135A2 (en) Porcine parvovirus 5b, methods of use and vaccine